Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
16 studies found for:    Open Studies | "Carcinoma, Small Cell"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Small Cell"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma
Condition: Small Cell Carcinoma
Interventions: Drug: Nortriptyline Hydrochloride;   Drug: Paclitaxel
2 Recruiting Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study
Condition: Carcinoma, Small Cell
Intervention: Radiation: Whole brain radiotherapy with reduced dose to the hippocampi
3 Recruiting TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
Condition: Carcinoma, Small Cell
Intervention: Drug: ARQ197
4 Recruiting HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer
Condition: Carcinoma, Small Cell Lung
Interventions: Radiation: HS-WBRT PCI;   Radiation: Conventional PCI
5 Not yet recruiting Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: hypofractionated concurrent chemoradiotherapy;   Radiation: conventionally fractionated concurrent chemoradiotherapy
6 Not yet recruiting Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: high-dose TRT;   Radiation: standard-dose TRT
7 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
8 Recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Conditions: Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Extrapulmonary Small Cell Cancer;   Pulmonary Neuroendocrine Tumors;   Thymic Epithelial Tumors
Intervention:
9 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
10 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD6244;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
11 Recruiting International Ovarian & Testicular Stromal Tumor Registry
Conditions: Ovarian Stromal Tumor;   Testicular Stromal Tumors;   Ovarian Small Cell Carcinoma
Intervention:
12 Not yet recruiting Olaparib With or Without Cediranib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation;   Prostate Carcinoma Metastatic in the Bone;   Prostate Small Cell Carcinoma;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Cediranib;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib
13 Recruiting PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Conditions: Neuroendocrine Tumors;   Carcinoma, Small Cell Lung;   Carcinoma, Large Cell Lung;   Merkel Cell Carcinoma;   Pheochromocytoma;   Paraganglioma;   Thyroid Cancer, Medullary;   Neuroendocrine Carcinoma
Intervention: Drug: PEN-221
14 Recruiting Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Conditions: Cancer of the Lung;   Lung Cancer;   Lung Neoplasms;   Adenocarcinoma of the Lung;   Non Small Cell Carcinoma of the Lung;   Small Cell Carcinoma of the Lung
Intervention:
15 Not yet recruiting A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer
Condition: Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
Interventions: Drug: Durvalumab and Tremelimumab;   Drug: AZD1775 and carboplatin (CBPT)
16 Recruiting Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix
Condition: Cervical Cancer
Intervention: Behavioral: Questionnaires

Study has passed its completion date and status has not been verified in more than two years.